Podcasts about quetiapine

Send Me a Message! In this episode of The Dysregulated Podcast, I explore the vital role Seroquel plays in my ability to get a good night's sleep and how its absence leaves me battling through the day. Sleep deprivation exacerbates the negative ruminations that seem to take centre stage of my psyche, and today, they've been particularly focused on my inner workaholic—the sub-part of me constantly pushing to apply for new jobs and to (hopefully) improve my life! That is one part of me that doesn't slow down, even if the self has! Join me as I do my best to explain the challenges of sleeplessness, self-criticism, and the weight of unrelenting expectations, all before the Seroquel kicks in and I finally get some rest!-Follow my journey living with mental illness and the hard-fought lessons learned along the way. Lived experience is the driving force of this podcast, and through this lens, my stories are told. This is a raw, honest, and authentic account of how multiple psychological disorders have shaped my past and continue to influence my future.Support the showTo support the show, CLICK HEREYou can follow me on Instagram: @elliot.t.waters

Welcome back and Happy New Year! Today, we are kicking it off with a brief episode on Quetiapine (Seroquel).

How does the food we eat impact the way our bodies absorb and metabolize medications? What do we have to be aware of if we are eating a low-carb, high-fat ketogenic diet, and how it's going to impact so many of the medications people with mental illness are taking? In this engaging interview with psychopharmacology expert Dr. Deanna Kelly, you'll learn how the food you eat can influence the effectiveness of mental health medications such as Cobenfy and the extended-release form of Quetiapine, where absorption rates are affected by high-fat meals. Dr. Kelly shares valuable insights on optimizing psychiatric care with individualized approaches, revealing practical tips for patients and practitioners alike. This conversation is essential viewing for those interested in the latest strategies in metabolic psychiatry and the powerful role of nutrition in mental health care. *Experts featured* Deanna L. Kelly, PharmD, BCPP https://www.medschool.umaryland.edu/profiles/kelly-deanna/ X: @ProfDeannaK https://www.linkedin.com/in/deanna-l-kelly-pharmd-bcpp-3a8b299b/ *Related Publications* _Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions_ https://pmc.ncbi.nlm.nih.gov/articles/PMC11054576/ *Related Videos* https://youtu.be/tzPlQ6dJwe8 *Sign Dr. Christopher Palmer's Petition to Reinstate the Study* https://bit.ly/3Ap8Oe4 About us: Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #KetogenicMetabolicTherapy #NutritionalKetosis#KetogenicTherapy#Depression#Schizophrenia#Keto#PsychMeds

This is the 36th episode in my drug name pronunciation series.  In this episode, I divide quetiapine and Seroquel into syllables, tell you which syllables to emphasize, and share my sources.  The written pronunciations are below and in the show notes for episode 290 on thepharmacistsvoice.com.   Quetiapine = kwe-TYE-a-peen Emphasize TYE Source: USP Dictionary Online    Seroquel = SA-ruh-kwil (like Sarah + Quill) Emphasize the 1st syllable, SA. Source: My experience in clinical practice   Thank you for listening to episode 290 of The Pharmacist's Voice ® Podcast.   To read the FULL show notes (including all links), visit https://www.thepharmacistsvoice.com/podcast.  Select episode 290.   If you know someone who needs to learn how to say quetiapine or Seroquel, please share this episode with them.  Please subscribe for all future episodes.  This podcast is on all major podcast players and YouTube.  Some popular podcast player links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Links from this episode USP Dictionary Online (Subscription-based resource) USP Dictionary's pronunciation guide (Free resource on The American Medical Association's website)  Seroquel medication guide on the FDA's website  The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin)  The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine)  The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec)  The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol)  The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC)  The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide)  The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta   Kim's websites and social media links: ✅Business website https://www.thepharmacistsvoice.com ✅The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅Pronounce Drug Names Like a Pro © Online Course https://www.kimnewlove.com  ✅A Behind-the-scenes look at The Pharmacist's Voice ® Podcast © Online Course https://www.kimnewlove.com  ✅LinkedIn https://www.linkedin.com/in/kimnewlove ✅Facebook https://www.facebook.com/kim.newlove.96 ✅Twitter https://twitter.com/KimNewloveVO ✅Instagram https://www.instagram.com/kimnewlovevo/ ✅YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 290 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Internationally renowned bipolar disorder expert Dr. Trisha Suppes unravels the latest science in bipolar disorder treatment by breaking down the proven and cutting-edge treatments available today - exploring traditional solutions such as Lithium and mood stabilizers alongside exciting new options like psilocybin, ketamine, and the Ketogenic diet. Dr. Suppes also navigates the complexities of mania and tackles the perennial question: is lifelong medication necessary to live well with bipolar disorder? (00:00) About Dr. Suppes Medication Treatments (03:00) Is Lithium the Gold Standard? (05:22) Atypical Antipsychotics (07:22) Dangers of Antidepressants? (09:17) Medications Lose Strength? Non-medication Treatments (10:47) Psychotherapy (12:54) Ketogenic Diet & Nutrition (13:28) Cannabis (14:20) Ketamine Brain Stimulation Therapies (15:18) rTMS (Transcranial Magnetic Stimulation) (16:01) VNS (Vagus Nerve Stimulation) (17:07) ECT (Electroconvulsive Therapy) Bipolar Disorder is Complex (18:52) Insight & Denying Bipolar Disorder (22:45) Bipolar I: Need Meds Forever? (23:44) Bipolar II: Need Meds Forever? (26:22) Hypomania Causes Misdiagnosis (28:16) Mixed States Psychedelics (29:28) Psilocybin & Magic Mushrooms (32:33) Microdosing & LSD (34:02) MDMA Closing (35:41) Keeping You "A Little Depressed" (37:55) Why Recovery Is Possible (39:06) Reflecting on Research Impact Dr. Trisha Suppes, M.D., Ph.D., is a distinguished expert on the biology and treatment of bipolar disorder, and mood disorders generally. Dr. Suppes is the Director of Exploratory Therapeutics and Professor at Stanford University in the School of Medicine. At the VA Palo Alto Health Care System, she is Director of the CSP NODES and is the Founder of the Bipolar and Depression Research Program. Her areas of expertise include long-term treatment strategies for bipolar disorder, identification and treatment of bipolar II disorder, treatment of those with bipolar disorders and co-morbid conditions and use of complementary medicine. She has recently launched a new initiative to explore the use of psychedelics for mood disorders and PTSD in Veterans. Dr. Suppes has been integrally involved in numerous initiatives to improve evidence-based treatment for bipolar disorders. Dr. Suppes participated as a member of the DSM-5 Mood Disorders committee on updating the APA DSM-5 criteria for Mood Disorders and was chair of the APA DSM-5 Bipolar Disorder subcommittee. She was the past President of the International Society of Bipolar Disorders (ISBD). Treatments Referenced

When should women begin receiving biennial screening for breast cancer? Find out about this and more in today's PeerDirect Medical News Podcast.

Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug's approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.

The case of Kouri Richins, accused of poisoning her husband Eric with a lethal mix of fentanyl and Quetiapine, has taken a dark and complex turn. Psychologist John Delatorre joined Tony Brueski on the "Hidden Killers" podcast to unravel the psychological aspects of this alleged crime.    The conversation begins with a critical question: "Did Kouri Richins meticulously plan her husband's murder, or was it an act of desperation?" This question sets the stage for an in-depth analysis of the case and the mind of the accused.    Brueski outlines the allegations against Richins, highlighting the discovery of Quetiapine, an antipsychotic drug used as a sleep aid, in her husband's system. Delatorre explains the drug's typical use and speculates on Richins' possible reasoning. "She probably thinks that it's going to put her husband to sleep and then the rest of the fentanyl will just kill him in a sort of pseudo peaceful way," he suggests, shedding light on the potential thought process behind the alleged poisoning.    The discussion shifts to the psychological profile of someone who would commit such a crime. Delatorre emphasizes that perpetrators of poisoning no longer see their victims as human beings, which allows them to rationalize their actions. "There's no longer any of that social contract that we have that makes it so that we need to be cooperative with one another," he notes, explaining the detachment involved in such crimes.    Brueski and Delatorre also delve into the narcissistic aspects of poisoning as a method of murder. They discuss how it allows the perpetrator to avoid direct violence while potentially gaining sympathy as a grieving loved one. "Is poisoning kind of the narcissist's ultimate way of killing someone if they can get away with it?" Brueski asks, highlighting the manipulative nature of such crimes.    Delatorre points out that Richins' subsequent actions, such as writing a book and appearing on TV, suggest a premeditated plan for attention and gain. "It does seem to be premeditated in some way," he asserts, considering the calculated nature of her follow-up behaviors.    As the episode concludes, Brueski and Delatorre leave the audience with a thought-provoking question: "In a case as chilling and complex as Kouri Richins', can we ever truly understand the motivations behind such a heinous act, or will the true intent remain shrouded in mystery?" This question encapsulates the uncertainty and intrigue surrounding a case that continues to captivate and confound observers. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

The case of Kouri Richins, accused of poisoning her husband Eric with a lethal mix of fentanyl and Quetiapine, has taken a dark and complex turn. Psychologist John Delatorre joined Tony Brueski on the "Hidden Killers" podcast to unravel the psychological aspects of this alleged crime.    The conversation begins with a critical question: "Did Kouri Richins meticulously plan her husband's murder, or was it an act of desperation?" This question sets the stage for an in-depth analysis of the case and the mind of the accused.    Brueski outlines the allegations against Richins, highlighting the discovery of Quetiapine, an antipsychotic drug used as a sleep aid, in her husband's system. Delatorre explains the drug's typical use and speculates on Richins' possible reasoning. "She probably thinks that it's going to put her husband to sleep and then the rest of the fentanyl will just kill him in a sort of pseudo peaceful way," he suggests, shedding light on the potential thought process behind the alleged poisoning.    The discussion shifts to the psychological profile of someone who would commit such a crime. Delatorre emphasizes that perpetrators of poisoning no longer see their victims as human beings, which allows them to rationalize their actions. "There's no longer any of that social contract that we have that makes it so that we need to be cooperative with one another," he notes, explaining the detachment involved in such crimes.    Brueski and Delatorre also delve into the narcissistic aspects of poisoning as a method of murder. They discuss how it allows the perpetrator to avoid direct violence while potentially gaining sympathy as a grieving loved one. "Is poisoning kind of the narcissist's ultimate way of killing someone if they can get away with it?" Brueski asks, highlighting the manipulative nature of such crimes.    Delatorre points out that Richins' subsequent actions, such as writing a book and appearing on TV, suggest a premeditated plan for attention and gain. "It does seem to be premeditated in some way," he asserts, considering the calculated nature of her follow-up behaviors.    As the episode concludes, Brueski and Delatorre leave the audience with a thought-provoking question: "In a case as chilling and complex as Kouri Richins', can we ever truly understand the motivations behind such a heinous act, or will the true intent remain shrouded in mystery?" This question encapsulates the uncertainty and intrigue surrounding a case that continues to captivate and confound observers. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

The case of Kouri Richins, accused of poisoning her husband Eric with a lethal mix of fentanyl and Quetiapine, has taken a dark and complex turn. Psychologist John Delatorre joined Tony Brueski on the "Hidden Killers" podcast to unravel the psychological aspects of this alleged crime.    The conversation begins with a critical question: "Did Kouri Richins meticulously plan her husband's murder, or was it an act of desperation?" This question sets the stage for an in-depth analysis of the case and the mind of the accused.    Brueski outlines the allegations against Richins, highlighting the discovery of Quetiapine, an antipsychotic drug used as a sleep aid, in her husband's system. Delatorre explains the drug's typical use and speculates on Richins' possible reasoning. "She probably thinks that it's going to put her husband to sleep and then the rest of the fentanyl will just kill him in a sort of pseudo peaceful way," he suggests, shedding light on the potential thought process behind the alleged poisoning.    The discussion shifts to the psychological profile of someone who would commit such a crime. Delatorre emphasizes that perpetrators of poisoning no longer see their victims as human beings, which allows them to rationalize their actions. "There's no longer any of that social contract that we have that makes it so that we need to be cooperative with one another," he notes, explaining the detachment involved in such crimes.    Brueski and Delatorre also delve into the narcissistic aspects of poisoning as a method of murder. They discuss how it allows the perpetrator to avoid direct violence while potentially gaining sympathy as a grieving loved one. "Is poisoning kind of the narcissist's ultimate way of killing someone if they can get away with it?" Brueski asks, highlighting the manipulative nature of such crimes.    Delatorre points out that Richins' subsequent actions, such as writing a book and appearing on TV, suggest a premeditated plan for attention and gain. "It does seem to be premeditated in some way," he asserts, considering the calculated nature of her follow-up behaviors.    As the episode concludes, Brueski and Delatorre leave the audience with a thought-provoking question: "In a case as chilling and complex as Kouri Richins', can we ever truly understand the motivations behind such a heinous act, or will the true intent remain shrouded in mystery?" This question encapsulates the uncertainty and intrigue surrounding a case that continues to captivate and confound observers. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

The case of Kouri Richins, accused of poisoning her husband Eric with a lethal mix of fentanyl and Quetiapine, has taken a dark and complex turn. Psychologist John Delatorre joined Tony Brueski on the "Hidden Killers" podcast to unravel the psychological aspects of this alleged crime.    The conversation begins with a critical question: "Did Kouri Richins meticulously plan her husband's murder, or was it an act of desperation?" This question sets the stage for an in-depth analysis of the case and the mind of the accused.    Brueski outlines the allegations against Richins, highlighting the discovery of Quetiapine, an antipsychotic drug used as a sleep aid, in her husband's system. Delatorre explains the drug's typical use and speculates on Richins' possible reasoning. "She probably thinks that it's going to put her husband to sleep and then the rest of the fentanyl will just kill him in a sort of pseudo peaceful way," he suggests, shedding light on the potential thought process behind the alleged poisoning.    The discussion shifts to the psychological profile of someone who would commit such a crime. Delatorre emphasizes that perpetrators of poisoning no longer see their victims as human beings, which allows them to rationalize their actions. "There's no longer any of that social contract that we have that makes it so that we need to be cooperative with one another," he notes, explaining the detachment involved in such crimes.    Brueski and Delatorre also delve into the narcissistic aspects of poisoning as a method of murder. They discuss how it allows the perpetrator to avoid direct violence while potentially gaining sympathy as a grieving loved one. "Is poisoning kind of the narcissist's ultimate way of killing someone if they can get away with it?" Brueski asks, highlighting the manipulative nature of such crimes.    Delatorre points out that Richins' subsequent actions, such as writing a book and appearing on TV, suggest a premeditated plan for attention and gain. "It does seem to be premeditated in some way," he asserts, considering the calculated nature of her follow-up behaviors.    As the episode concludes, Brueski and Delatorre leave the audience with a thought-provoking question: "In a case as chilling and complex as Kouri Richins', can we ever truly understand the motivations behind such a heinous act, or will the true intent remain shrouded in mystery?" This question encapsulates the uncertainty and intrigue surrounding a case that continues to captivate and confound observers. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

Shocking revelations have emerged in the case of Eric Richins, a Utah man allegedly poisoned to death by his wife, Kouri Richins, in March 2022. Unsealed search warrants have shed new light on the circumstances surrounding Eric's tragic demise, uncovering disturbing details about the events leading up to his death.    Kouri Richins, 33, faces grave charges of aggravated murder and drug possession after she was accused of killing her husband, Eric, with illicit fentanyl in their Kamas, Utah, residence. Eric, who had been married to Kouri for nine years and shared three children with her, tragically lost his life on March 3, 2022.    The recently unsealed search warrants reveal unsettling findings that raise questions about the circumstances of Eric's death. According to a Summit County detective's report, it was discovered that Eric had a small amount of Quetiapine (brand name SEROQUEL) in his stomach contents at the time of his death. The alarming aspect was that Eric did not possess a prescription for Quetiapine, but his wife did, and the pills were readily available in their home.  Quetiapine is classified as an antipsychotic medication used to treat various mental health conditions, including schizophrenia and bipolar disorder. It acts by balancing the levels of dopamine and serotonin in the brain. However, the medication is known to carry a range of potentially dangerous side effects, such as hyperglycemia, fever, stroke, pain, seizures, and more.    Prosecutors in the case have suggested that Eric's murder may have been financially motivated, revealing a troubling backdrop to the tragic events. According to court documents, the couple had been embroiled in financial disagreements, particularly related to Kouri's desire to acquire a $2 million mansion that was under construction at the time. Her plan was to purchase the property, renovate it, and then sell it for a profit.    However, Eric believed the mansion's price was exorbitant, a sentiment that his family conveyed to investigators. Additionally, Kouri had taken out four different life insurance policies on Eric's life between 2015 and 2017, totaling more than $1.9 million. Notably, on January 1, 2022, just months before Eric's tragic death, Kouri clandestinely altered the beneficiary of a $2 million life insurance policy, making herself the recipient without Eric's authorization.    Before his death, Eric had removed Kouri from his will and designated his sister as the new beneficiary, a move that suggested he had concerns about his safety. His family informed authorities that he had feared for his life, citing previous incidents where Kouri allegedly attempted to poison him, once several years ago in Greece and again on Valentine's Day 2022.    Following Eric's untimely death, Kouri authored a children's book titled "Are You With Me?" This book, listed on Amazon for $14.99, is described as "a must-read for any child who has experienced the pain of loss, and for parents who want to provide their children with the emotional support they need to heal and grow."    The unsealed search warrants have added a new layer of complexity to the ongoing legal proceedings in this high-profile case. Eric Richins' tragic death continues to be a subject of intense scrutiny, as investigators delve deeper into the circumstances surrounding his alleged poisoning and the subsequent legal actions against his wife, Kouri Richins. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

Shocking revelations have emerged in the case of Eric Richins, a Utah man allegedly poisoned to death by his wife, Kouri Richins, in March 2022. Unsealed search warrants have shed new light on the circumstances surrounding Eric's tragic demise, uncovering disturbing details about the events leading up to his death.    Kouri Richins, 33, faces grave charges of aggravated murder and drug possession after she was accused of killing her husband, Eric, with illicit fentanyl in their Kamas, Utah, residence. Eric, who had been married to Kouri for nine years and shared three children with her, tragically lost his life on March 3, 2022.    The recently unsealed search warrants reveal unsettling findings that raise questions about the circumstances of Eric's death. According to a Summit County detective's report, it was discovered that Eric had a small amount of Quetiapine (brand name SEROQUEL) in his stomach contents at the time of his death. The alarming aspect was that Eric did not possess a prescription for Quetiapine, but his wife did, and the pills were readily available in their home.  Quetiapine is classified as an antipsychotic medication used to treat various mental health conditions, including schizophrenia and bipolar disorder. It acts by balancing the levels of dopamine and serotonin in the brain. However, the medication is known to carry a range of potentially dangerous side effects, such as hyperglycemia, fever, stroke, pain, seizures, and more.    Prosecutors in the case have suggested that Eric's murder may have been financially motivated, revealing a troubling backdrop to the tragic events. According to court documents, the couple had been embroiled in financial disagreements, particularly related to Kouri's desire to acquire a $2 million mansion that was under construction at the time. Her plan was to purchase the property, renovate it, and then sell it for a profit.    However, Eric believed the mansion's price was exorbitant, a sentiment that his family conveyed to investigators. Additionally, Kouri had taken out four different life insurance policies on Eric's life between 2015 and 2017, totaling more than $1.9 million. Notably, on January 1, 2022, just months before Eric's tragic death, Kouri clandestinely altered the beneficiary of a $2 million life insurance policy, making herself the recipient without Eric's authorization.    Before his death, Eric had removed Kouri from his will and designated his sister as the new beneficiary, a move that suggested he had concerns about his safety. His family informed authorities that he had feared for his life, citing previous incidents where Kouri allegedly attempted to poison him, once several years ago in Greece and again on Valentine's Day 2022.    Following Eric's untimely death, Kouri authored a children's book titled "Are You With Me?" This book, listed on Amazon for $14.99, is described as "a must-read for any child who has experienced the pain of loss, and for parents who want to provide their children with the emotional support they need to heal and grow."    The unsealed search warrants have added a new layer of complexity to the ongoing legal proceedings in this high-profile case. Eric Richins' tragic death continues to be a subject of intense scrutiny, as investigators delve deeper into the circumstances surrounding his alleged poisoning and the subsequent legal actions against his wife, Kouri Richins. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

Shocking revelations have emerged in the case of Eric Richins, a Utah man allegedly poisoned to death by his wife, Kouri Richins, in March 2022. Unsealed search warrants have shed new light on the circumstances surrounding Eric's tragic demise, uncovering disturbing details about the events leading up to his death.    Kouri Richins, 33, faces grave charges of aggravated murder and drug possession after she was accused of killing her husband, Eric, with illicit fentanyl in their Kamas, Utah, residence. Eric, who had been married to Kouri for nine years and shared three children with her, tragically lost his life on March 3, 2022.    The recently unsealed search warrants reveal unsettling findings that raise questions about the circumstances of Eric's death. According to a Summit County detective's report, it was discovered that Eric had a small amount of Quetiapine (brand name SEROQUEL) in his stomach contents at the time of his death. The alarming aspect was that Eric did not possess a prescription for Quetiapine, but his wife did, and the pills were readily available in their home.  Quetiapine is classified as an antipsychotic medication used to treat various mental health conditions, including schizophrenia and bipolar disorder. It acts by balancing the levels of dopamine and serotonin in the brain. However, the medication is known to carry a range of potentially dangerous side effects, such as hyperglycemia, fever, stroke, pain, seizures, and more.    Prosecutors in the case have suggested that Eric's murder may have been financially motivated, revealing a troubling backdrop to the tragic events. According to court documents, the couple had been embroiled in financial disagreements, particularly related to Kouri's desire to acquire a $2 million mansion that was under construction at the time. Her plan was to purchase the property, renovate it, and then sell it for a profit.    However, Eric believed the mansion's price was exorbitant, a sentiment that his family conveyed to investigators. Additionally, Kouri had taken out four different life insurance policies on Eric's life between 2015 and 2017, totaling more than $1.9 million. Notably, on January 1, 2022, just months before Eric's tragic death, Kouri clandestinely altered the beneficiary of a $2 million life insurance policy, making herself the recipient without Eric's authorization.    Before his death, Eric had removed Kouri from his will and designated his sister as the new beneficiary, a move that suggested he had concerns about his safety. His family informed authorities that he had feared for his life, citing previous incidents where Kouri allegedly attempted to poison him, once several years ago in Greece and again on Valentine's Day 2022.    Following Eric's untimely death, Kouri authored a children's book titled "Are You With Me?" This book, listed on Amazon for $14.99, is described as "a must-read for any child who has experienced the pain of loss, and for parents who want to provide their children with the emotional support they need to heal and grow."    The unsealed search warrants have added a new layer of complexity to the ongoing legal proceedings in this high-profile case. Eric Richins' tragic death continues to be a subject of intense scrutiny, as investigators delve deeper into the circumstances surrounding his alleged poisoning and the subsequent legal actions against his wife, Kouri Richins. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

Shocking revelations have emerged in the case of Eric Richins, a Utah man allegedly poisoned to death by his wife, Kouri Richins, in March 2022. Unsealed search warrants have shed new light on the circumstances surrounding Eric's tragic demise, uncovering disturbing details about the events leading up to his death.    Kouri Richins, 33, faces grave charges of aggravated murder and drug possession after she was accused of killing her husband, Eric, with illicit fentanyl in their Kamas, Utah, residence. Eric, who had been married to Kouri for nine years and shared three children with her, tragically lost his life on March 3, 2022.    The recently unsealed search warrants reveal unsettling findings that raise questions about the circumstances of Eric's death. According to a Summit County detective's report, it was discovered that Eric had a small amount of Quetiapine (brand name SEROQUEL) in his stomach contents at the time of his death. The alarming aspect was that Eric did not possess a prescription for Quetiapine, but his wife did, and the pills were readily available in their home.  Quetiapine is classified as an antipsychotic medication used to treat various mental health conditions, including schizophrenia and bipolar disorder. It acts by balancing the levels of dopamine and serotonin in the brain. However, the medication is known to carry a range of potentially dangerous side effects, such as hyperglycemia, fever, stroke, pain, seizures, and more.    Prosecutors in the case have suggested that Eric's murder may have been financially motivated, revealing a troubling backdrop to the tragic events. According to court documents, the couple had been embroiled in financial disagreements, particularly related to Kouri's desire to acquire a $2 million mansion that was under construction at the time. Her plan was to purchase the property, renovate it, and then sell it for a profit.    However, Eric believed the mansion's price was exorbitant, a sentiment that his family conveyed to investigators. Additionally, Kouri had taken out four different life insurance policies on Eric's life between 2015 and 2017, totaling more than $1.9 million. Notably, on January 1, 2022, just months before Eric's tragic death, Kouri clandestinely altered the beneficiary of a $2 million life insurance policy, making herself the recipient without Eric's authorization.    Before his death, Eric had removed Kouri from his will and designated his sister as the new beneficiary, a move that suggested he had concerns about his safety. His family informed authorities that he had feared for his life, citing previous incidents where Kouri allegedly attempted to poison him, once several years ago in Greece and again on Valentine's Day 2022.    Following Eric's untimely death, Kouri authored a children's book titled "Are You With Me?" This book, listed on Amazon for $14.99, is described as "a must-read for any child who has experienced the pain of loss, and for parents who want to provide their children with the emotional support they need to heal and grow."    The unsealed search warrants have added a new layer of complexity to the ongoing legal proceedings in this high-profile case. Eric Richins' tragic death continues to be a subject of intense scrutiny, as investigators delve deeper into the circumstances surrounding his alleged poisoning and the subsequent legal actions against his wife, Kouri Richins. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, Justice for Harmony Montgomery, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, and much more! Listen at https://www.truecrimetodaypod.com

Episode 157: Urine TestingThis episode includes the pitfalls of urine tests, how to detect adulterated urine, and more.  Written by Janelli Mendoza, MSIV, Ross University School of Medicine. Editing by Hector Arreaza, MD. Comments by Carol Avila, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction: Urine drug screenings are valuable tools used every day by physicians to monitor illicit substance use, as well as proper use or misuse of prescription drugs. However, studies suggest that physicians using “clinical judgment” on who and when to test is often wrong and confounded by implicit racial bias. The implications of this are an inappropriate discontinuation of treatment.For example, a study by Gaither, Gordon, and Crystal et. al found that compared to white patients, black patients were 10% more likely to undergo urine drug screening. In addition, they were 2-3 times more likely to have long-term opioid medication abruptly discontinued as a result of a UTOX positive for marijuana.False positive urine tests:Before getting into the current guidelines, let's discuss the interpretation of Urine Drug Screenings. It's important to be aware of prescription drugs that may cause false positives:· Bupropion, labetalol, pseudoephedrine, trazodone → Amphetamines· HIV antivirals, sertraline → Benzodiazepines· HIV antivirals, NSAIDs, PPI's → Cannabinoids· Diphenhydramine, Naloxone, Quetiapine, Quinolones, Verapamil → Opioids· Dextromethorphan, diphenhydramine, ibuprofen, tramadol, venlafaxine → PhencyclidineTampering of urine: Other factors to consider are the tampering of collected urine. The tampering of collected urine may include diluting the urine, or adding other chemicals and substances. Laboratory results that should prompt consideration of adulteration are: Creatinine

For almost 11 years, Laurie was taking Seroquel/Quetiapine. It got her though a lot - and was the first mental health medication she found really "worked" for her.  After a lot of thought, side effects, and conversations with her doctor - Laurie decided to try and taper of of the medication slowly. Our Patreon supporters will remember this time well as Laurie shared a series of bonus episodes throughout the taper and subsequent withdrawal. Without going into as much detail as the patreon diary style episodes, Laurie wanted to chat with someone who knew the science of medications better than she did. In this episode, Carly (from our The Borderline Doctor) episode shares some insights with Laurie about how Seroquel works, why she was likely experiencing some withdrawal symptoms, and how we can better our sleep with or without sleep-aids. Carly (@daturadxm) is a life coach and works in the alternative healthcare space. Into her work, she brings the medical education she received in school before she was dismissed from her program after taking a mental health leave. She is now fighting back against the stigma against borderline personality disorder in education which forced her out of medical school.While we say it many times during the episode - CARLY IS NOT A DOCTOR and THIS EPISODE IS NOT MEDICAL ADVISE.  This is simply a conversation between two people who have taken this medication, one who has a much better understanding of how it works from a scientific perspective than the other. ALWAYS CONSULT YOUR HEALTH CARE PROVIDER WHEN CHANGING MEDICATIONS. Support the showYou can find Laurie and Sara on Instagram to follow their day to day lives even further @laurieanned and @saraswellnessway. You can also find the podcast on IG @boldbeautifulborderline Leave us a voicemail about your thoughts on the show at boldbeautifulborderline.comRegister for our free peer support group at https://www.eventbrite.ca/e/the-super-feelers-club-tickets-145605434775Register for our low-barrier drop-in DBT group at https://www.thewellnesswayllc.comPurchase the Exploring Your Borderline Strengths Journal at https://www.amazon.com/Exploring-Your-Borderline-Strengths-Amundson/dp/B0C522Y7QT/ref=sr_1_1?crid=IGQBWJRE3CFX&keywords=exploring+your+borderline+strengths&qid=1685383771&sprefix=exploring+your+bor%2Caps%2C164&sr=8-1 If you like the show we would love if you could rate, subscribe and support us on Patreon. Patreon info here: https://www.patreon.com/boldbeautifulborderline?fan_landing=true ...

There are many reasons why patients misuse medications. Today, Joseph Pierre shakes us out of our 1990s understanding of addiction and explains a new trend, misuse of uncontrolled medications like Bupropion, Quetiapine and the Gabapentinoids.CME: Take the CME Post-Test for this EpisodePublished On: 10/23/2023Duration: 24 minutes, 34 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This is the 17th podcast episode for the Psychiatric Medication Podcast Series. Series Description: Current literature indicates that podcasts can be an effective educational format to reach health professionals across the continuum of medical education, addressing a myriad of topics pertinent to providers. This episode serves as an overview of Quetiapine/Seroquel. This podcast season is the second released by East Carolina University's Office of Continuing Medical Education and may be beneficial for physicians, residents, fellows, nurse practitioners, physician assistants, and nurses. This podcast season is comprised of approximately 30 episodes, each focusing on different psychiatric medications for the non-psychiatric provider. Those tuning into the podcast's second season will receive a primer on the "bread and butter" behavioral health medications for primary care: antidepressants, antipsychotics, and mood stabilizers. Episodes will be released weekly on Wednesdays.Rachel Gooding, MD & Amizetta Clark, MD

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: May 28, 2020 Lewy body dementia may be the second most common neuropathologic cause of dementia behind Alzheimer disease, but it remains largely a clinical diagnosis with limited treatment options. This week on BrainWaves, Dr. Amy Colcher (Cooper University Hospital) reviews the diagnostic criteria and management strategies for patients and their caregivers who suffer from this condition. Plus, a sort of tribute to Robin Williams. Produced by James E Siegler and Amy Colcher. Music courtesy of Andrew Sacco, Axletree, Damiano Baldoni, Josh Woodward, and Julie Maxwell. The opening theme was composed by Jimothy Dalton. Sound effects by Mike Koenig and Daniel Simion. Unless otherwise mentioned in the podcast, no competing financial interests exist in the content of this episode. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision-making. Be sure to follow us on Twitter @brainwavesaudio for the latest updates to the podcast. REFERENCES Armstrong MJ. Lewy body dementias. Continuum (Minneap Minn) 2019;25(1):128-46. PMID 30707190 Desmarais P, Massoud F, Filion J, Nguyen QD, Bajsarowicz P. Quetiapine for psychosis in Parkinson disease and neurodegenerative parkinsonian disorders: a systematic review. J Geriatr Psychiatry Neurol 2016;29(4):227-36. PMID 27056066 Frieling H, Hillemacher T, Ziegenbein M, Neundörfer B, Bleich S. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol 2007;17(3):165-71. PMID 17070675 Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord 2010;16(6):388-92. PMID 20434939 Koga S, Aoki N, Uitti RJ, et al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 2015;85(5):404-12. PMID 26138942 McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017;89(1):88-100. PMID 28592453 McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin 2000;18(4):865-902. PMID 11072265 Stinton C, McKeith I, Taylor JP, et al. Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. Am J Psychiatry 2015;172(8):731-42. PMID 26085043 Taylor JP, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol 2020;19(2):157-69. PMID 31519472  We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

Send us a Text Message.

This is one of my drug name pronunciation episodes.  Today, we're talking about tianeptine.   How do these pronunciation episodes work?   I break drug names down into syllables.   I explain which syllable has the emphasis.   I reveal the source of the information.  I put the written pronunciation in the show notes so that you see it and use it right away.   If you're new to my pronunciation episodes, welcome!  The purpose is to provide the intended pronunciations of drug names from reliable sources so that you feel more confident saying them and less frustrated learning them.  I hope this episode helps you! Why did I pick tianeptine for this episode? To talk about the pronunciation  To improve awareness about it   Highlights from this episode Written pronunciation = Tye uh NEP teen Tianeptine has 4 syllables. Tye - like you tie your shoes Uh - schwa “A” sound  Nep - like the planet Neptune Teen - like a teenager

Download the cheat: https://bit.ly/50-meds  View the lesson:     Generic Name quetiapine Trade Name Seroquel Indication schizophrenia, depressive disorder, mania Action dopamine and serotonin antagonist Therapeutic Class antipsychotic, mood stabilizers Pharmacologic Class none Nursing Considerations • may cause neurolyptic malignant syndrome, seizures, dizziness, palpitations, weight gain, anorexia • QT interval prolongation • don't use with CNS depressants • assess weight frequently • monitor liver function test and CBC • may increase cholesterol

In this podcast episode, Marwan Sabbagh, MD, FAAN, and Marta San Luciano, MD, MS, FAAN, have a conversation about Parkinson's disease psychosis (PDP). Their discussion provides information on the disease itself—covering symptoms, risk factors, and mechanism—before moving into clinical strategies for diagnosis and disease and comorbidity management. The experts emphasize the importance of ruling out an underlying cause of psychosis before making a diagnosis of PDP, calling out common culprits such as urinary and respiratory tract infections. Following diagnosis, they comment on the value of implementing nonpharmacologic measures in tandem with pharmacologic interventions for PDP. Within the discussion of pharmacologic interventions, Drs Sabbagh and San Luciano give a well-rounded explanation of patient and medication factors they consider when choosing a treatment for their patients with PDP, including patient outcomes they have experienced in clinical practice. Rounding out the podcast, the experts touch on their approach to managing the very common comorbidity of sleep disturbances in patients with PDP.Presenters:Marwan Sabbagh, MD, FAANProfessor of NeurologyAlzheimer's and Memory Disorders DivisionDepartment of NeurologyBarrow Neurological InstitutePhoenix, ArizonaMarta San Luciano, MD, MS, FAANAssociate Professor of NeurologyUniversity of California, San FranciscoAttending NeurologistNeurology/Movement Disorders and Neuromodulation CenterUniversity of California, San Francisco Medical CenterSan Francisco, CaliforniaThis content is based on a CE/CME program supported by an independent educational grant from Acadia Pharmaceuticals, Inc.For additional activities in this program, visithttp://bit.ly/3tPMqnr

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 11, 2022, issue.

12 clinically relevant findings from the past 3 years on quetiapine (Seroquel), including new side effects, dosing strategies, withdrawal phenomena, and new uses in bipolar with OCD.CME: Podcast CME Post-Tests are available using this subscription. If you have already enrolled in that program, please log in.Published On: 06/6/2022Duration: 20 minutes, 27 secondsReferenced Article: “Quetiapine Reconsidered,” The Carlat Child Psychiatry Report, June 2022Chris Aiken, MD, Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

On this episode, I discuss quetiapine pharmacology, adverse effects, pharmacokinetics, and drug interactions.

Quetiapine is also known by the brand name Seroquel. It comes as both an immediate release and extended release formulation. There are several indications such as for schizophrenia and various classifications of Bipolar disorder. It can also be used as adjunct treatment in major depressive disorder. The max dose for quetiapine is 800 mg/day. Doses are generally divided bid-tid. Quetiapine's antipsychotic activity is proposed to be a result of both dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism. There are many other antagonist effects on neurotransmitter receptors in the brain such as 5HT1A, 5HT2, D1, D2, H1, and adrenergic alpha1/alpha3 receptors. There is a black box warning for dementia related psychosis and suicidality. Common side effects are somnolence, weight gain, and constipation. Quetiapine should never be stopped abruptly after prolonged usage. Go to DrugCardsDaily.com for episode show notes which consist of the drug summary, quiz, and link to the drug card for FREE! Please SUBSCRIBE, FOLLOW, and RATE on Spotify, Apple Podcasts, or wherever your favorite place to listen to podcasts are. The main goal is to go over the Top 200 Drugs with the occasional drug of interest. Also, if you'd like to say hello, suggest a drug, or leave some feedback I'd really appreciate hearing from you! Leave a voice message at anchor.fm/drugcardsdaily or find me on twitter @drugcardsdaily --- Send in a voice message: https://anchor.fm/drugcardsdaily/message

April is an actor and producer, and an Ambassador for Bipolar UK. April started her own company at 21 to bring stability to her career as an Actor. For April working for herself works better than working for someone else, so this career path she feels is best suited to her. April lives with Bipolar type 2 and Borderline Personality Disorder; she has suffered since she was 15 but didn't receive diagnosis and help until she was 27. She has been on medication since the age of 18 and feels that in the last year she has stepped into therapy whole heartedly after hitting rock bottom. We talk about how receiving a diagnosis can be bittersweet and how this can land so differently for us all and how Bipolar can be partly genetic and partly triggered by trauma. When April was diagnosed, April's dad said “I always knew there was a stroke of genius inside of you” The feeling of being invincible and absolute certainty that we are able to carry out an immense number of tasks without any doubt in our highest selves versus how low we can go and not be able to even to the smallest of tasks. We talk about the differences in our experiences of taking Quetiapine, April's hunger has been totally suppressed and in my experience my hunger was insatiable, and I needed 3 breakfasts before I my normal level of hunger came through for a normal hunger. We both know the feeling of a medication hangover and how it can take a few hours in the morning to shift. We also talk about how experiencing balanced mood is something that feels alien to us after having spent most of your life affected by Bipolar. Inner child work can be very healing in learning how to reparent our younger selves and offer those parts of us compassion, grace, love and understanding. April is currently working through these parts of her journey and grieving for the parts of our lives in the past where we were doing our best and forgive ourselves for the things we didn't know at the time and do know now. TW: Auditory intrusions, Hypomanic, Paranoia and Mania Please find support and resources on our website: Website www.bipolaruk.org Insta: bipolar_uk Twitter: bipolaruk Facebook: bipolaruk Find the links to April's profiles below: IG: @april_kelley Twitter: @april__kelley www.aprilkelley.com Hosted by Emma Belle IG @emmakbelle www.emmakbelle.com

Can biologics lower COVID-19 hospitalization risk in patients with psoriasis? Find out about this and more in today's PV Roundup podcast.

Sanjay Gupta, MD, conducts a Masterclass on treating geriatric patients with symptoms of dementia, particularly amid the restrictions tied to COVID-19. Dr. Gupta is chief medical officer at BryLin Hospital in Buffalo, N.Y. He is also is a clinical professor in the department of psychiatry at the State University of New York, Syracuse, and is affiliated with SUNY at Buffalo. Dr. Gupta attends at 8-10 nursing homes. He disclosed serving on the speakers’ bureaus of AbbVie, Acadia, Alkermes, Intra-Cellular Therapies, Janssen, and Otsuka. Take-home points Common neuropsychiatric symptoms in patients with dementia include agitation, aggression, delusions, insomnia, anxiety, and depression. One-third of community-dwelling elders and between 60%-80% of nursing facility patients have these neuropsychiatric symptoms. The most common medication class Dr. Gupta uses is antipsychotics. The use of these medications in individuals with dementia is off label. The Food and Drug Administration maintains a black-box warning on the use of antipsychotics for geriatric patients because of the increased risk of sudden death. Risperidone is supported by the most data, then olanzapine, then aripiprazole, and finally quetiapine. Quetiapine has very limited data to support its efficacy. Most antipsychotics have modest efficacy data for their use in this population. The riskiest adverse effects are cardiovascular adverse events, which are higher in risperidone. Dr. Gupta starts risperidone at a low dose of 0.25 mg taken by mouth b.i.d. and titrates to a maximum dose of 2 mg/24 hours. The starting dose for olanzapine is 2.5 mg up to a maximum dose of 10 mg. The starting dose of aripiprazole is 1 mg, and maximum dose 5 mg or less. Selective serotonin reuptake inhibitors (most commonly sertraline or citalopram), the atypical antidepressant mirtazapine, and anticonvulsants (valproic acid) are also used for agitation in dementia but there is limited evidence for their efficacy. Melatonin and trazodone have a positive effect on sleep that can have downstream improvement on aggressive behaviors. Summary To choose an effective treatment, it’s essential to obtain a detailed history of the symptoms from patients and collateral, such as relatives and staff members from the facility. Staff members can be educated about what information is most important to the clinician, or they may provide vague information, such as “the patient is confused.” Specific symptoms that can be used guide treatment include the presence of disorganized thoughts, delusions and paranoia, or visual and/or auditory hallucinations; the timing of the behavior (day vs. night); and patterns of aggressive behaviors. Dr. Gupta emphasizes that it’s important to rule out delirium as the cause of agitation by evaluating underlying medical issues with laboratory evaluations, and when possible, a physical exam. Antipsychotics work best in the context of aggression driven by paranoia and/or delusions of persecution. Antipsychotics seem to work less well for general agitation that may be driven by triggers that need to be uncovered through investigation of the history and environment. Reasons for agitation and aggression might include sensory or activity deprivation, difficulty emptying bladder or bowels, or depression and loneliness, both of which are prevalent during the pandemic. Adverse effects of antipsychotics will be greater in older adults, and include sedation, gait problems that increase the risk of falls, and extrapyramidal or Parkinsonian symptoms. In a geriatric patient, tardive dyskinesia can occur with as little as 1 month of exposure to an antipsychotic, compared with 3 months in younger adults. Before starting an antipsychotic, the clinician must obtain informed consent from the health-care proxy and inform them that using antipsychotics in a patient with dementia is a non–FDA-approved treatment with a black-box warning. Gradual dose reduction, a Medicare policy about the use of psychotropic medications within nursing homes, is defined as “stepwise tapering of a dose to determine if symptoms, conditions, or risks can be managed by a lower dose or if the dose or medication can be discontinued.” Dr. Gupta addresses this policy by assessing which medications are essential and often stopping some medications once the patient is started on antipsychotics. References Steinberg M, Lyketsos CG. Am J Psychiatry. 2012 Sep;169(9):900-6. Maher AR et al. JAMA. 2011 Sep 28;306(12):1359-69. Schneider LS et al. JAMA. 2005 Oct 19;294(15):1934-43. Seitz DP et al. Cochrane Database Sys Rev. 2001 Feb 16;(12):CD0089. Ballard C et al. Cochrane Database Sys Rev. 2006 Jan 25. doi: 10.1002/14651858. Ballard C, Waite J. Cochrane Database Sys Rev. 2006 Jan 25;(1):CD003476. Department of Health & Human Services. State Operations Manual Surveyor Guidance Revisions Related to Psychosocial Harm in Nursing Homes. CMS.gov. 2016 Mar 25. *  *  * Show notes by Jacqueline Posada, MD, associate producer of the Psychcast; assistant clinical professor in the department of psychiatry and behavioral sciences at George Washington University, Washington; and staff physician at George Washington Medical Faculty Associates, also in Washington. Dr. Posada has no conflicts of interest. *  *  * For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com

Chris Aiken, MD, and Kellie Newsome, PMH-NP, discuss how to dose quetiapine for the treatment of bipolar disorder. Dr Aiken is the Mood Disorders Section Editor for Psychiatric Times, the Editor in Chief of The Carlat Psychiatry Report, (https://thecarlatreport.com/) and the Director of the Mood Treatment Center. (http://www.moodtreatmentcenter.com/) His written several books on mood disorders, most recently The Depression and Bipolar Workbook (https://www.amazon.com/Depression-Bipolar-Workbook-Strengthen-Brain/dp/1683732359) . He can be heard in the weekly Carlat Psychiatry Podcast (https://podcasts.apple.com/us/podcast/the-carlat-psychiatry-podcast/id1463414537) with his co-host Kellie Newsome, PMH-NP. Dr Aiken does not accept honoraria from pharmaceutical companies but receives royalties from PESI for The Depression and Bipolar Workbook (https://www.amazon.com/Depression-Bipolar-Workbook-Strengthen-Brain/dp/1683732359) and from W.W. Norton & Co. for Bipolar, Not So Much (https://www.amazon.com/Bipolar-Not-Much-Understanding-Depression/dp/0393711749/ref=sr_1_1?ie=UTF8&qid=1483750639&sr=8-1&keywords=bipolar+not+so+much) . Kellie L. Newsome, PMH-NP, is the cohost of the Carlat Psychiatry Podcast and is also a practicing Psychiatric Mental Health Nurse Practitioner in Winston Salem, NC, at the Mood Treatment Center. Raised in Tasmania, Australia, Kellie moved to the United States in 1998. For more on this topic, see Top Mood Stabilizers for Bipolar Disorder (https://www.psychiatrictimes.com/view/new-answers-treatment-resistant-depression) .

This episode Matt goes into the affect Bipolar disorder and psychosis can have on your life, while he self administrates Seroquel

Lewy Body Dementia may be the second most common neuropathologic cause of dementia behind Alzheimer disease, but it remains largely a clinical diagnosis with limited treatment options. This week on BrainWaves, Dr. Amy Colcher (Cooper University Hospital) reviews the diagnostic criteria and management strategies for patients and their caregivers who suffer from this condition. Plus, a sort of tribute to Robin Williams. ** IF YOU’RE TAKING YOUR NEUROLOGY BOARDS THIS SUMMER, CHECK OUT THE PENN NEUROLOGY BOARD REVIEW COURSE AT https://upenn.cloud-cme.com/default.aspx?P=5&EID=65373. AND FOR A DISCOUNTED RATE ON THE ONLINE OR STREAMING RESOURCES, USE PROMO CODE ‘WAVES2020’. ** Produced by James E. Siegler and Amy Colcher. Music courtesy of Andrew Sacco, Axletree, Damiano Baldoni, Josh Woodward, and Julie Maxwell. The opening theme was composed by Jimothy Dalton. Sound effects by Mike Koenig and Daniel Simion. Unless otherwise mentioned in the podcast, no competing financial interests exist in the content of this episode. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making. Be sure to follow us on Twitter @brainwavesaudio for the latest updates to the podcast. REFERENCES McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin. 2000;18:865-902. Frieling H, Hillemacher T, Ziegenbein M, Neundorfer B and Bleich S. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol. 2007;17:165-71. Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A and Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. 2010;16:388-92. Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW and Dickson DW. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85:404-12. Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A and O'Brien JT. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry. 2015;172:731-42. Desmarais P, Massoud F, Filion J, Nguyen QD and Bajsarowicz P. Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review. J Geriatr Psychiatry Neurol. 2016;29:227-36. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M and Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88-100. Armstrong MJ. Lewy Body Dementias. Continuum (Minneap Minn). 2019;25:128-146. Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ and O'Brien JT. New evidence on the management of Lewy body dementia. The Lancet Neurology. 2020;19:157-169.

Alberto J. Espay, MD, MSc, conducts a Masterclass lecture on treating patients with Parkinson’s-related psychosis from the Psychopharmacology Update in Cincinnati. The meeting was sponsored by Global Academy for Medical Education and Current Psychiatry. Dr. Espay is professor of neurology at the University of Cincinnati. He also serves as director of the James J. and Joan A. Gardner Family Center Research Chair for Parkinson’s Disease and Movement Disorders. And later, in the “Dr. RK” segment, Renee Kohanski, MD, asks you to think about some of the complex issues tied to getting treatment for people who are both homeless and have serious mental illness.  *  *  *  Treatment of Parkinson’s-related psychosis  Psychosis related to Parkinson’s disease (PD) is a common reason for hospitalization, institutionalization, and decline of patients with PD. The diagnosis of PD is required before the development of psychosis to diagnose patients with Parkinson's-related psychosis. Parkinsonism that appears after development of psychosis is Lewy body dementia. Many factors influence the development of psychosis in PD. Extrinsic factors include medical illnesses or metabolic derangement causing delirium with psychosis; nonessential dopaminergic medications such as ropinirole and selegiline; anticholinergic medications such as benztropine, amantadine, and bladder antispasmodics; and insomnia. The last resort for treatment of psychosis is levodopa because patients will experience motoric decline and loss of functioning. There are several mechanisms for psychosis to occur via the dopaminergic, serotonergic, and glutamatergic pathways; thus, three neurotransmitters – serotonin, dopamine, and glutamate – can be manipulated to treat psychosis. Quetiapine, clozapine, and pimavanserin are the three antipsychotics safe for use in Parkinson’s disease. Clozapine is infrequently used, because of the risk of neutropenia and required blood work monitoring, but evidence shows that the benefits usually outweigh the risks of motor decline. Quetiapine is commonly used, because it has a favorable effect on sleep and psychosis, but it negatively affects the movement disorder of Parkinson's disease. Pimavanserin (Nuplazid), the only medication FDA approved for hallucinations and delusions associated with psychosis in Parkinson’s disease, is highly selective for the 5-HT2A receptor as both an inverse agonist and antagonist. Primary adverse effects are peripheral edema and confusion, but overall the adverse effects profile is similar to that of placebo. In the pimavanserin clinical trials, a subset of patients worsened and experienced more visual hallucinations. In addition, pimavanserin can prolong the QT interval, so patients taking other QT-prolonging medications or who have cardiac comorbidities should be monitored with an EKG. Post hoc data analysis from as pivotal phase 3 study suggests that patients with cognitive impairment and dementia may receive more benefit from pimavanserin.   *  *  *  References Cruz MP. Pimavanserin (Nuplazid): A treatment for hallucinations and delusions associated with Parkinson’s disease. P T. 2017 Jun;42(6):368-71. Cummings J et al. Pimavanserin: Potential treatment for dementia-related psychosis. J Prev Alzheimers Dis. 2018;5(4):253-8. Huot P. 5HT2A receptors and Parkinson’s disease psychosis: A pharmacological discussion. Neurodegenerative Disease Management. 2018 Nov 19. doi: 10.2217/nmt-2018-0039.  *  *  *  For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgePsych  

This week, Thomas Kim, David Rosenthal, and Audrey Provenzano bring you a journal club episode. Audrey talks about: Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial by Adam Sacarny, PhD, Michael L. Barnett, MD, MS, Jackson Le, PharmD, Frank Tetkoski, RPh, David Yokum, PhD & Shantanu Agrawal, MD. David Rosenthal talks about Effect of Community Health Worker Support on Clinical Outcomes of Low-Income Patients Across Primary Care Facilities: A randomized Control trial By Shreya Kangovi , Nadita Mitra, Lindsey Norton, Rory Harte, Xinzi Zhao, Tamala Carter, David Grande, and Judith Long. Thomas Kim brings us a discussion of Women from racial or ethnic minority and low socioeconomic backgrounds receive more prenatal education: Results from the 2012 to 2014 Pregnancy Risk Assessment Monitoring System by Minh N. Nguyen PhD, Mohammad Siahpush PhD, Brandon L. Grimm PhD, Gopal K. Singh PhD & Melissa K. Tibbits PhD. If you enjoy the show, please give us 5 stars wherever you listen. Tweet us your thoughts @RoSpodcast and leave us a message on our facebook page at www.facebook.com/reviewofsystems. Or, you can email me at audrey@rospod.org. We’d love to hear from you, and thanks for listening.

Today’s question is: How to treat sleep disturbances in patients with PTSD?   Here is a summary of this episode: Prazosin is recommended as a first-line agent in sleep disturbances in PTSD with an average dose for men at 16 mg and for women, 7 mg titrated over 5 weeks. Trazodone can be used in patients with initial-sleep insomnia with PTSD at a starting dose of 50 mg. Avoid benzodiazepines due to its abuse potential. Also, its cognitive side effects may negatively affect psychotherapy effectiveness. Quetiapine should not be used first-line in the treatment of insomnia. It is associated with weight gain, which is not dose-related. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute 

The post Quetiapine (Seroquel) Nursing Pharmacology Considerations appeared first on NURSING.com.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers the treatment of generalized anxiety disorder with Dr. Jared Peck, a Staff Psychiatrist at Mount Sinai Hospital in Toronto. In this episode, Jordan Bawks (PGY2 resident) and Bruce Fage (PGY4 resident) reunite with Dr. Peck to talk about the bio-psycho-social management of GAD. They cover recommended lifestyle changes for people with GAD, evidence-based pharmacotherapies, including SSRIs, SNRIs, Pregabalin, Quetiapine, TCAs and benzodiazepines, and how to choose between them, and psychotherapeutic treatments with a focus on CBT and a quick overview of some of the third wave cognitive models. By the end of this episode, the listener will be able to… List the lifestyle changes recommended for people with GAD Describe the first line and second line medication therapies for GAD and the rationale supporting each agent's place in the treatment hierarchy  Appreciate the key elements of CBT that make it effective for the treatment of GAD Relevant Articles: Generoso et al., 2017 (Pregabalin for GAD metaanalysis) Katzman et al., 2014 (Canadian Anxiety Guidelines) Perrin et al., 2019 (Laval model) Please Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association or the University of Toronto and are not meant to replace formal clinical education or judgment. For more PsychEd, follow us on Twitter (@psychedpodcast) and Facebook. You can provide feedback by email at psychedpodcast@gmail.com For more information visit our website: psychedpodcast.org.

We apologize to our listeners for our show being late this week. We are coming to you directly from the Exploring Psychedelics Conference at Southern Oregon University, and preparations and travel have slowed down the release of this week's episode. On Today's Episode of the podcast, Jonathan talks with Jon Bridge. Jon is  a 34 year old father of two. from Canada. The two met through a Facebook Group, The Terence McKenna Experience, thanks to Jon's willingness to share his inspiring story of hope and healing. Jonathan felt called to respond almost immediately after the posting appeared on his feed, and the two connected to share Jon's story. Jon's experience of the failure of standard  psychiatricpharmaceutical drugs  and his journey back to health with the help of psilocybin mushrooms and a clear understanding that the conditions that ailed him for years did not have to be permanent, or simply "managed" with ill-understood collections of molecules. Jon [I was on] daily doses of high strength, high dose pharmaceutical garbage. I was supposed to be a customer for life. Although I have no credentials behind my name I have a story of healing and hope. I had been a long time sufferer of mental illness but thanks to psychedelic medicines I have discovered a new, better self. My journey into psychedelic healing has just begun and I hope to be able to inspire someone to help themselves. Jon's "before" picture, on the let, is dated March 20, 2010, exactly 6 years before the date of his Facebook post..Looking in the eyes, it feels possible to almost see the changed interior landscape behind them. This is a story that our listeners will not want to miss. (None of Jon or Jonathan's remarks should be interpreted as psychiatric advice. Neither is a licensed therapist. Changes in medicines should be done with the partnership of a qualified professional.) Thanks to everyone who "Liked" Psychedelic Parenting on Facebook and helped us reach our goal of 1000 page likes by the end of March. As of 3/31/16 at 11:59pm, we had 1017 page likes! Thanks again to all who clicked, shared or clickshared... And, as always, if you like what you see and hear, please consider a tax-deductible contribution to the work. Help us keep the podcast streaming and the website improving! Click the purple button below to contribute to Psychedelic Parenting via MAPS Click HERE to join our mailing list or become a part of our "Secret" Facebook discussion group. TOPICS AND WEBSITES DISCUSSED IN THIS EPISODE: Exploring Psychedelics Conference Home Page Facebook Page Grateful Meds Dispensary, Talent, Oregon Home Page Oregon Cannabis Connections: "Third Grateful Meds Dispensary Opens in Talent" Pharmeceutical Products Cyprolex (Generic: Escitalopram) Tryptophan Lithium Seroquel (Generic: Quetiapine) Wellbutrin (Generic: Bupropion) Citalopram (Brand Names: Celexa, Cipramil) Divalproex (Valporate) Stopping Psychiatric Drugs  For specific dangers and symptoms and helpful guidelines for coming off psychotropics, see Coming off Psychiatric Medication  Ketamine Erowid.org page WebMD: "Ketamine: The Future of Depression Treatment?" ClinicalTrials.gov: "Rapid Antidepressant Effects of Ketamine in Major Depression" Vice.com: "I Used Ketamine to Treat My Depression" Ketamine Advocacy Network: "Provider Directory" Dextromethorphan ("DXM") Erowid.org: "DXM Vault" Psilocybin Erowid.org: "Psilocybin Mushroom Vault" Vice.com: "What it Feels Like to Treat Depression with Magic Mushrooms" New York Times: "Can Mushrooms Treat Depression?" The New Yorker: "The Trip Treatment" By Michael Pollan Mixing Psilocybin and Cannabis (as Jon describes in his story) Shroomery.org forums: "Cannabis and Mushrooms" Erowid Experience Vaults: "Rendered Eternal, Mushrooms and Cannabis" Santa as Shaman When Santa Was a Shaman: Ancient Origins of Santa Claus and the Christmas Tree  by Tony van Renterghem NPR.org: "Did 'Shrooms Send Santa and his Reindeer Flying?" Reality Sandwich: "Shaman Claus: The Shamanic Origins of Christmas" Plenty of Fish (POF) Free Online Dating Service

On this week's episode we're talking about surviving in the workplace, divorcing on Facebook, and how we understand surveillance issues. We're also answering your questions about student discounts, iPad virus dissemination, and Chrome extensions.